Search
XOMA Royalty Corp
XOMAAdd to Watchlist
41.591USD
-0.409-0.97%
Market hours （ET）Quotes delayed by 15 min
495.34MMarket Cap
25.17P/E TTM
More Details of XOMA Royalty Corp Company
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.
XOMA Royalty Corp Info
Ticker SymbolXOMA
Company nameXoma Royalty Corp
IPO dateJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Number of employees13
Security typeOrdinary Share
Fiscal year-endJun 06
Address2200 Powell Street
CityEMERYVILLE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94608
Phone15102047200
Websitehttps://xoma.com/
Ticker SymbolXOMA
IPO dateJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Company Executives of XOMA Royalty Corp
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Switzerland
23.96M
45.94%
United States
23.09M
44.28%
Asia Pacific
4.10M
7.86%
Australia
1.00M
1.92%
Europe
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BVF Partners L.P.
20.65%
Morgan Stanley Investment Management Inc. (US)
13.56%
Fidelity Management & Research Company LLC
8.95%
BlackRock Institutional Trust Company, N.A.
4.44%
Vanguard Capital Management, LLC
4.38%
Other
48.01%
Shareholders
Shareholders
Proportion
BVF Partners L.P.
20.65%
Morgan Stanley Investment Management Inc. (US)
13.56%
Fidelity Management & Research Company LLC
8.95%
BlackRock Institutional Trust Company, N.A.
4.44%
Vanguard Capital Management, LLC
4.38%
Other
48.01%
Shareholder Types
Shareholders
Proportion
Hedge Fund
26.59%
Investment Advisor
25.35%
Investment Advisor/Hedge Fund
22.12%
Individual Investor
4.16%
Research Firm
0.36%
Bank and Trust
0.12%
Pension Fund
0.04%
Insurance Company
0.03%
Other
21.24%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
133
8.37M
67.32%
--
2026Q1
161
9.75M
80.84%
+1.08M
2025Q4
154
8.45M
68.20%
+59.30K
2025Q3
138
8.25M
68.26%
+399.67K
2025Q2
147
7.87M
65.79%
+337.12K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BVF Partners L.P.
2.59M
21.74%
--
--
Dec 31, 2025
Morgan Stanley Investment Management Inc. (US)
1.70M
14.27%
+65.08K
+3.98%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.12M
9.42%
+85.40K
+8.24%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
556.42K
4.67%
+12.24K
+2.25%
Dec 31, 2025
Opaleye Management Inc.
292.59K
2.46%
+37.50K
+14.70%
Dec 31, 2025
Woodline Partners LP
262.93K
2.21%
+52.99K
+25.24%
Dec 31, 2025
Geode Capital Management, L.L.C.
221.57K
1.86%
+9.59K
+4.52%
Dec 31, 2025
Hughes (Owen P.)
180.99K
1.52%
+82.43K
+83.63%
Mar 16, 2026
State Street Investment Management (US)
174.91K
1.47%
+7.87K
+4.71%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Small Cap Equity ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.06%
ProShares Hedge Replication ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
